The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index; 37 of the 51 sources its claims cite were checked for support.
Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease
Open accessAbstract
Alzheimer's disease (AD) is the most common cause of dementia worldwide due to an aging population. AD is characterized as a progressive neurodegenerative disease that leads to atrophy of brain tissue, causing cognitive deficits. Amyloid beta plaques and neurofibrillary tangles are pathological hallmarks of AD, yet the cause is still highly debated. Many other cardiovascular diseases and vascular manifestations share the same symptoms as patients with AD. In this review, the current understanding of AD is summarized with a brief discussion on how primary cilia dysfunction and impaired nitric oxide (NO) signaling contribute to cardiovascular risk factors, vascular pathology, and cognitive decline in AD. Finally, we highlight primary cilia as a possible therapeutic target and any future directions for treating AD.
Overview
CoChat Summary
## TL;DR
This review argues that primary cilia and nitric oxide (NO) signaling may connect cardiovascular risk factors, vascular dysfunction, and cognitive decline in Alzheimer’s disease (AD). It frames AD as involving both neuronal pathology and cerebrovascular/BBB damage, with ciliary dysfunction proposed as a possible therapeutic target.
## Key findings
- The review states that AD is the most common cause of dementia worldwide and notes that about 6.7 million Americans have been diagnosed, with a prevalence of 1 in 9 people aged 65+.
- Primary cilia are described as sensory organelles that detect blood flow and regulate NO release; when cilia fail to sense fluid shear stress, endothelial NO production decreases, which can contribute to hypertension, a reported risk factor for AD.
- In the cilia/Hedgehog section, the paper reports that Aβ deposition shortens cilia in vitro and in vivo, and in mouse NIH3T3 fibroblast cells Aβ caused a significant decrease in primary cilia length and in Shh downstream signaling.
- For vascular disease, the review cites a study of 404 brains showing a strong coincidence/correlation between AD and cerebral amyloid angiopathy (CAA), and multiple biomarker/imaging studies linking BBB disruption with AD.
## Methods
- This is a narrative review of prior literature on AD, primary cilia, NO signaling, cardiovascular risk factors, and vascular pathology.
- The paper synthesizes findings from human studies, animal models, and cell experiments, including studies of 404 brains, three observational European cohorts, four studies in a systematic review, and mouse/NIH3T3 experiments.
- The main approach is conceptual synthesis, not original data analysis; it links reported evidence across ciliary signaling, endothelial dysfunction, BBB leakage, hypertension, diabetes, and amyloid pathology.
## Limitations
- The paper does not report any original sample, cohort, or statistical analysis of its own; this is evident from the text.
- The authors explicitly state that the mechanism of pathology between cilia and AD has not been identified and that further investigations are needed to understand the connection between primary cilia, NO, and AD.
- The text makes evident that much of the evidence is indirect, associative, or preclinical (cell and animal studies), so causal claims remain limited; this is evident from the review’s framing.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 2 Illustration of the structure of primary cilia. The primary cilia are made up of the ciliary membrane, axoneme, and basal body. The ciliary membrane contains protein receptors and channels responsible for proper cilia function. The axoneme forms the ciliary skeleton, while the basal body is anchored to the plasma membrane with the help of the centrioles. Figure is adopted with permission from [50].](https://figures.cochat.ai/paper-figures/d3a52765712943bfafa2fe6e5cc031ad/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-2.jpg)
![Figure 3 Healthy (left) vs. dysfunctional (right) blood brain barrier (BBB). BBB dysfunction may be caused by a disruption in the endothelial cells, leading to decreased tight junction expression and increased vascular permeability. Tight junction protein expression has also been reduced in the presence of Amyloid Beta 42 (Aβ42). Low-density lipoprotein receptor-related protein 2 (LRP2), Glucose Transporter Type 1 (GLUT1), very-low-density-lipoprotein receptor (VLDLR), Permeability Glycoprotein (Pgp), Major facilitator superfamily domain-containing protein 2 (MFSD2a), receptor for advanced glycation end products (RAGE), red blood cell (RBC). Figure is adopted with permission from [102].](https://figures.cochat.ai/paper-figures/7f44746ca65c4bdfa121cbc8f4b6cdb7/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-3.jpg)
![Figure 1 Primary vascular endothelial cilia play a role in the biochemical production of nitric oxide (NO), a potent vasodilator. The figure illustrates how NO is produced in an artery. In physiological conditions, a rise in blood pressure will be detected through the mechanosensory role of primary cilia as a result of increased vascular shear stress. The bending or activation of these cilia involves the mechanosensory polycystin-1 and polycystin-2 complex, triggering a signaling cascade that leads to NO production. This cascade includes an influx of extracellular calcium ions (Ca2+), which subsequently activates several calcium-dependent proteins, such as calmodulin (CaM) and protein kinase C (PKC). Along with protein kinase B (PKB), CaM and PKC act as key downstream effectors that activate endothelial nitric oxide synthase (eNOS), the enzyme responsible for NO synthesis. Figure is adopted with permission from [21].](https://figures.cochat.ai/paper-figures/40eb905bf51640268709dc7f5bb4af51/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-1.jpg)
![Figure 4 NO signaling in healthy vs. Alzheimer’s disease primary cilia. Primary cilia are sensory organelles that extend from the surface of endothelial cells into the blood vessel lumen, where they detect extracellular stimuli and convert them into intracellular biochemical signals, such as NO. In Alzheimer’s Disease Aβ accumulation can possibly disrupt downstream signaling pathways, leading to impaired vascular function and cognitive decline but the exact mechanism is still unclear. Created in part with BioRender Premium [111] (https://help.biorender.com/hc/en-gb/articles/17605447498269-BioRender-Premium accessed on 10 September 2025).](https://figures.cochat.ai/paper-figures/70e54ba812d044f19691afa26ecdda3c/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-4.jpg)
Verification
Claims the paper makes
32 Valid · 0 Not valid · 13 Not checked · 4 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The shortening of cilia can impair their ability to sense and regulate external signals, leading to the promotion of AD [47].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 2. Primary Cilia and Ciliary Receptors
What the sources say
- Supportedcites [47] Guo, 2025, Changes of the Primary Cilia in Alzheimer’s Disease Pathogenesis, Eur. J. Neurosci. source
The Discussion states that shortened cilia may impair their ability to sense and regulate external signals, thereby promoting AD progression. The citing sentence paraphrases that qualified claim. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently, neuroinflammation, especially through microglial overactivation and the nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3 (NLRP3) inflammasome, has gained recognition as a major driver of neuronal damage in AD, fueling a destructive cycle of reduced amyloid clearance and ongoing degeneration [9].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 1. Introduction
What the sources say
- Supportedcites [9] Kamila, 2025, Effect of neuroinflammation on the progression of Alzheimer’s disease and its significant ramifications for novel anti-inflammatory treatments, IBRO Neurosci. Rep. sourceExperimental — accuracy not yet measured
The Introduction describes chronic neuroinflammation as a key driver of AD, and “Factors facilitating neuroinflammation” links chronic microglial activation to progressive neuronal damage. “Impact of astrocytes, neuroglia, and cell mediators” describes inefficient microglial activation and impaired Aβ clearance, and links NLRP3 activation to further Aβ aggregation and AD progression. The review supports the cited sentence as a synthesis of these mechanisms, rather than stating that NLRP3 itself directly reduces clearance. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In relation to AD, it has been shown that Aβ deposition can cause cilia length to shorten in vitro and in vivo [47,48].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 2. Primary Cilia and Ciliary Receptors
What the sources say
- Partly supportedcites [47] Guo, 2025, Changes of the Primary Cilia in Alzheimer’s Disease Pathogenesis, Eur. J. Neurosci. sourceExperimental — accuracy not yet measured
Section 3.1 reports that Aβ 1-42 treatment shortened primary cilia in cultured cells and neurons. Section 3.2 finds shorter neuronal cilia closer to Aβ deposits in AD-model mice, but this in vivo association does not establish that deposition caused the shortening. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [48] Kobayashi, 2022, Impairment of ciliary dynamics in an APP knock-in mouse model of Alzheimer’s disease, Biochem. Biophys. Res. Commun. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypertension in older adults leads to maladaptation of the cerebral circulation, causing a disruption in the blood–brain barrier (BBB) and oxidative stress [86].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 4. Cardiovascular Risk Factors
What the sources say
- Supportedcites [86] Ungvari, 2021, Hypertension-induced cognitive impairment: From pathophysiology to public health, Nat. Rev. Nephrol. source
The Age-related maladaptation section says ageing impairs cerebral arteries’ adaptation to hypertension, allowing high pressure to reach vulnerable microvessels. The Adaptation of the cerebral circulation section links this pressure to worsened BBB disruption, while Oxidative stress and cellular resilience links it to increased oxidative stress in older adults. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A systematic review of four studies showed a direct association between hypertension and AD neuropathic change [87].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 4. Cardiovascular Risk Factors
What the sources say
- Partly supportedcites [87] Abdulrahman, 2022, Hypertension and Alzheimer’s disease pathology at autopsy: A systematic review, Alzheimer’s Dement. sourceExperimental — accuracy not yet measured
The Discussion says four studies reported a direct association between hypertension and AD neuropathological change. However, the Results state that the systematic review included 15 studies, not four, and that findings across studies were inconsistent. Four is the number reporting a direct association, not the number reviewed. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
22 more claims · 13 with their cited sources checked
Create a free account to see all 49 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 19
Citations
Cites
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 2×
“Whether it be through passive diffusion, solute carriers, ATP-binding cassette (ABC) transporters, or transcytosis, smaller, highly lipid-soluble, or polar molecules are able to pass through the BBB [101].”
Oxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837 · cited 5×
“But an overload of ROS can lead to the onset or progression of various cancers, diabetes, and atherosclerosis [65].”
InfluentialClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · cited 1×
“It is hypothesized that the AD process begins about 20 years before the clinical onset of dementia [2].”
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803 · cited 2×
“This pattern is being used in the diagnostic criteria of AD as an imaging biomarker in amyloid PET [134,135].”
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · cited 2×
“A different model is being developed to look at A β and tau accumulation as part of a cellular phase of AD pathogenesis instead of a sequential pathway [137].”
Masters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853 · cited 4×
“This pattern is being used in the diagnostic criteria of AD as an imaging biomarker in amyloid PET [134,135].”
InfluentialBlood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · cited 3×
“One study looked at brain capillary damage using PDGFR β as a CSF biomarker and dynamic contrast-enhanced MRI [121].”
InfluentialGenes and molecular pathways underpinning ciliopathies
Reiter, J. F., & Leroux, M. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.60 · Cited by 1,588 · cited 1×
“These diseases, caused by genetic and non-genetic mutations that disrupt primary cilia structure and/or function, include Bardet-Biedl Syndrome, Joubert syndrome, Polycystic kidney disease, some cancers, cardiovascular diseases, osteoarthritis, and neurodegenerative disorders such as AD [128].”
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“Associations have been documented between AD and different disease states, such as gastrointestinal disorders, diabetes, depression, and cardiovascular diseases [16–19].”
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“In the BBB, the low-density lipoprotein receptor-related protein 1 (LRP1) plays a major role in maintaining A β homeostasis and mediates transport of A β across the BBB into circulation [105,106].”
Cited by
Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects
Yang, Z., 唐永松, Guan, B., Zhao, C., Shang, Y., Xiong, M., Xu, M., Liu, Y., Qin, Z., Yang, Z., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121878
Metadata
- Authors
- Sunderman, C. L., Forero, K. V., Alorjani, Q., Buqaileh, R., Gallagher, G. M., Ventresca, S. M., Messer, W. S., & AbouAlaiwi, W. A.
- Affiliations
- University of Toledo (US)
- Corresponding author
- AbouAlaiwi, Wissam A.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2025-09-17
- Volume
- 15
- Issue
- 9
- Pages
- 1004
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC12468187
- OpenAlex
- W4414298326
- Cited by
- 1
- References
- 142
- Citations by year
- 2026: 1
- FWCI
- 0.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Toledo Office of Research and Sponsored Programs (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- Alzheimer’s Association (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- NIA (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- NHLBI (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- Alzheimer's disease, primary cilia, cardiovascular risk factors, nitric oxide signaling, vascular pathology, cognitive decline, amyloid plaques, neurofibrillary tangles, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease. https://app.cochat.ai/papers/10.3390/brainsci15091004
- The paper
- Sunderman, C. L., Forero, K. V., Alorjani, Q., Buqaileh, R., Gallagher, G. M., Ventresca, S. M., Messer, W. S., & AbouAlaiwi, W. A. (2025). Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease. Brain Sciences. https://doi.org/10.3390/brainsci15091004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.